Michael Recht/LinkedIn
Nov 26, 2025, 14:52
WFH Committee Member Highlight: Michael Recht on the Effectiveness of Octocog Alfa in Haemophilia A
World Federation of Hemophilia (WFH) shared on LinkedIn:
” Real-world data tell a powerful story.
In a recent study Octocog Alfa (BAY 81-8973) has shown effectiveness for people with hemophilia A, including under-represented groups, in the ATHN dataset.”
WFH has shared a committee member highlight from Michael Recht.
Read the full article here.
Article: Effectiveness of Octocog Alfa (BAY 81-8973) to Treat People With Haemophilia A Enrolled in the ATHNdataset, Including Under-Represented Subgroups
Authors: Martin Chandler, Thomas Moulton, Lena Charafi, Jessica Charlet, Michael Recht
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis